Literature DB >> 20861272

Thogoto virus infection induces sustained type I interferon responses that depend on RIG-I-like helicase signaling of conventional dendritic cells.

Georg Kochs1, Stefanie Bauer, Carola Vogt, Theresa Frenz, Jürg Tschopp, Ulrich Kalinke, Zoe Waibler.   

Abstract

Type I interferon (IFN-α/β) induction upon viral infection contributes to the early antiviral host defense and ensures survival until the onset of adaptive immunity. Many viral infections lead to an acute, transient IFN expression which peaks a few hours after infection and reverts to initial levels after 24 to 36 h. Robust IFN expression often is conferred by specialized plasmacytoid dendritic cells (pDC) and may depend on positive-feedback amplification via the type I IFN receptor (IFNAR). Here, we show that mice infected with Thogoto virus (THOV), which is an influenza virus-like orthomyxovirus transmitted by ticks, mounted sustained IFN responses that persisted up to 72 h after infection. For this purpose, we used a variant of THOV lacking its IFN-antagonistic protein ML, an elongated version of the matrix (M) protein [THOV(ΔML)]. Of note, large amounts of type I IFN were also found in the serum of mice lacking the IFNAR. Early IFN-α expression seemed to depend on Toll-like receptor (TLR) signaling, whereas prolonged IFN-α responses strictly depended on RIG-I-like helicase (RLH) signaling. Unexpectedly, THOV(ΔML)-infected bone marrow-derived pDC (BM-pDC) produced only moderate IFN levels, whereas myeloid DC (BM-mDC) showed massive IFN induction that was IPS-1-dependent, suggesting that BM-mDC are involved in the massive, sustained IFN production in THOV(ΔML)-infected animals. Thus, our data are compatible with the model that THOV(ΔML) infection is sensed in the acute phase via TLR and RLH systems, whereas at later time points only RLH signaling is responsible for the induction of sustained IFN responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20861272      PMCID: PMC2976394          DOI: 10.1128/JVI.00931-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Live viral vectors: vaccinia virus.

Authors:  Caroline Staib; Gerd Sutter
Journal:  Methods Mol Med       Date:  2003

2.  Thogoto virus lacking interferon-antagonistic protein ML is strongly attenuated in newborn Mx1-positive but not Mx1-negative mice.

Authors:  Andreas Pichlmair; Johanna Buse; Stephanie Jennings; Otto Haller; Georg Kochs; Peter Staeheli
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

3.  Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology.

Authors:  C Asselin-Paturel; A Boonstra; M Dalod; I Durand; N Yessaad; C Dezutter-Dambuyant; A Vicari; A O'Garra; C Biron; F Brière; G Trinchieri
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

Review 4.  Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance.

Authors:  Melissa Swiecki; Marco Colonna
Journal:  Immunol Rev       Date:  2010-03       Impact factor: 12.988

Review 5.  Antiviral actions of interferons.

Authors:  C E Samuel
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

6.  Characterization of the murine alpha interferon gene family.

Authors:  Vincent van Pesch; Hanane Lanaya; Jean-Christophe Renauld; Thomas Michiels
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

7.  Identification of Lps2 as a key transducer of MyD88-independent TIR signalling.

Authors:  K Hoebe; X Du; P Georgel; E Janssen; K Tabeta; S O Kim; J Goode; P Lin; N Mann; S Mudd; K Crozat; S Sovath; J Han; B Beutler
Journal:  Nature       Date:  2003-07-20       Impact factor: 49.962

8.  Novel gene product of Thogoto virus segment 6 codes for an interferon antagonist.

Authors:  Kathrin Hagmaier; Stephanie Jennings; Johanna Buse; Friedemann Weber; Georg Kochs
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

9.  Viral infection switches non-plasmacytoid dendritic cells into high interferon producers.

Authors:  Sandra S Diebold; Maria Montoya; Hermann Unger; Lena Alexopoulou; Polly Roy; Linsey E Haswell; Aymen Al-Shamkhani; Richard Flavell; Persephone Borrow; Caetano Reis e Sousa
Journal:  Nature       Date:  2003-06-22       Impact factor: 49.962

10.  Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo.

Authors:  Winfried Barchet; Marina Cella; Bernhard Odermatt; Carine Asselin-Paturel; Marco Colonna; Ulrich Kalinke
Journal:  J Exp Med       Date:  2002-02-18       Impact factor: 14.307

View more
  8 in total

1.  Cell-intrinsic role for IFN-α-STAT1 signals in regulating murine Peyer patch plasmacytoid dendritic cells and conditioning an inflammatory response.

Authors:  Haiyan S Li; Alexander Gelbard; Gustavo J Martinez; Eiji Esashi; Huiyuan Zhang; Hoainam Nguyen-Jackson; Yong-Jun Liu; Willem W Overwijk; Stephanie S Watowich
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

2.  High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus.

Authors:  Vivian A Scheuplein; Janna Seifried; Anna H Malczyk; Lilija Miller; Lena Höcker; Júlia Vergara-Alert; Olga Dolnik; Florian Zielecki; Björn Becker; Ingo Spreitzer; Renate König; Stephan Becker; Zoe Waibler; Michael D Mühlebach
Journal:  J Virol       Date:  2015-01-21       Impact factor: 5.103

3.  Comparative Study of Ten Thogotovirus Isolates and Their Distinct In Vivo Characteristics.

Authors:  Jonas Fuchs; Kevin Lamkiewicz; Larissa Kolesnikova; Martin Hölzer; Manja Marz; Georg Kochs
Journal:  J Virol       Date:  2022-01-12       Impact factor: 6.549

4.  In Vivo Conditions Enable IFNAR-Independent Type I Interferon Production by Peritoneal CD11b+ Cells upon Thogoto Virus Infection.

Authors:  Georg Kochs; Martina Anzaghe; Stefanie Kronhart; Valentina Wagner; Patricia Gogesch; Stefanie Scheu; Stefan Lienenklaus; Zoe Waibler
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

Review 5.  Tick-Borne Viruses and Biological Processes at the Tick-Host-Virus Interface.

Authors:  Mária Kazimírová; Saravanan Thangamani; Pavlína Bartíková; Meghan Hermance; Viera Holíková; Iveta Štibrániová; Patricia A Nuttall
Journal:  Front Cell Infect Microbiol       Date:  2017-07-26       Impact factor: 5.293

Review 6.  Modeling Arboviral Infection in Mice Lacking the Interferon Alpha/Beta Receptor.

Authors:  Alejandro Marín-Lopez; Eva Calvo-Pinilla; Sandra Moreno; Sergio Utrilla-Trigo; Aitor Nogales; Alejandro Brun; Erol Fikrig; Javier Ortego
Journal:  Viruses       Date:  2019-01-08       Impact factor: 5.048

7.  Development of multivalent vaccine targeting M segment of Crimean Congo Hemorrhagic Fever Virus (CCHFV) using immunoinformatic approaches.

Authors:  Maaza Sana; Aneela Javed; Syed Babar Jamal; Muhammad Junaid; Muhammad Faheem
Journal:  Saudi J Biol Sci       Date:  2021-12-10       Impact factor: 4.052

Review 8.  Antiviral type I and type III interferon responses in the central nervous system.

Authors:  Frédéric Sorgeloos; Marguerite Kreit; Pascale Hermant; Cécile Lardinois; Thomas Michiels
Journal:  Viruses       Date:  2013-03-15       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.